06.07.2020 | Letter to the Editor
Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept
Erschienen in: World Journal of Urology | Ausgabe 9/2021
Einloggen, um Zugang zu erhalten